Optimized Cord Blood Transplant

Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
54 patients (estimated)
Sponsors
Fred Hutchinson / University of Washington Cancer Consortium
Collaborators
National Cord Blood Network
Tags
Cord Blood
Trial Type
Treatment
Last Update
3 weeks ago
SparkCures ID
1758
NCT Identifier
NCT06013423

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.